LQDA(Liquidia Corporation) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $12.85M | $15.94M | $17.49M | $14.00M | $158.32M |
| 毛利润 | $9.83M | $13.08M | $14.60M | $8.12M | — |
| 营业利润 | −$33.80M | −$38.77M | −$73.38M | −$121.29M | −$51.38M |
| 净利润 | −$34.58M | −$41.02M | −$78.50M | −$128.29M | −$68.92M |
| 经营现金流 | −$34.03M | −$28.59M | −$41.56M | −$93.42M | −$35.69M |
| 自由现金流 | −$34.14M | −$29.18M | −$42.85M | −$98.37M | −$40.02M |
| 摊薄每股收益 | $-0.70 | $-0.67 | $-1.21 | $-1.63 | $-0.80 |